![Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indications - Ala - 2021 - Fundamental & Clinical Pharmacology - Wiley Online Library Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indications - Ala - 2021 - Fundamental & Clinical Pharmacology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3a083529-8c19-48f3-aee5-d970d2765dd5/fcp12633-fig-0001-m.jpg)
Sildenafil beyond erectile dysfunction and pulmonary arterial hypertension: Thinking about new indications - Ala - 2021 - Fundamental & Clinical Pharmacology - Wiley Online Library
![Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond | Nature Reviews Drug Discovery Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond | Nature Reviews Drug Discovery](https://media.springernature.com/w300/springer-static/image/art%3A10.1038%2Fnrd2030/MediaObjects/41573_2006_Article_BFnrd2030_Figb_HTML.jpg)
Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond | Nature Reviews Drug Discovery
![Molecular therapy for pulmonary arterial hypertension: Sildenafil [Brand name: Revatio, Viagra and others], a cGMP-specific phosphodiestrase type 5 inhibitor used in the treatment of erectile dysfunction and pulmonary hypertension, inhibits the development Molecular therapy for pulmonary arterial hypertension: Sildenafil [Brand name: Revatio, Viagra and others], a cGMP-specific phosphodiestrase type 5 inhibitor used in the treatment of erectile dysfunction and pulmonary hypertension, inhibits the development](https://genomediscovery.org/wp-content/uploads/2018/01/Sildenafil-attenuates-Pulmonary-Arterial-Hypertension-through-down-regulation-of-Notch-3-and-Hes-5-1.jpg)
Molecular therapy for pulmonary arterial hypertension: Sildenafil [Brand name: Revatio, Viagra and others], a cGMP-specific phosphodiestrase type 5 inhibitor used in the treatment of erectile dysfunction and pulmonary hypertension, inhibits the development
![Persistent pulmonary hypertension of the newborn: recent advances in pathophysiology and treatment | Jornal de Pediatria Persistent pulmonary hypertension of the newborn: recent advances in pathophysiology and treatment | Jornal de Pediatria](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0021755713000594:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w93hKAyzskf8PBiLZ7YkJaa2350iU51d/ftqFPJYABkIqDGaLLm2CZKmXK8fviD91fa6PTZq89th839A5MkJlLnR4LebNaVaAj6ofIOmurx6mDNMr8JqbMWwJP/DQZYAUB9+sA8wFdd7v7Owg8J3TpFPQe6dESB7odZHa69jOLKglBpKVnXfvnLgRbou2sdTdOgIQspcLY6EtCtGOLBl1ymhgpBfEKNLBxFjFgDOulTxZruQCfzeXZPxmEN5qJ40lodF1R/k73CqAIYlu9OzhecA=)
Persistent pulmonary hypertension of the newborn: recent advances in pathophysiology and treatment | Jornal de Pediatria
![Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again | Journal of the American Heart Association Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/59e07c3d-74ca-49db-ac13-98600306a966/jah33757-fig-0003.png)
Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again | Journal of the American Heart Association
![Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn - Pediatrics & Neonatology Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn - Pediatrics & Neonatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e243973a-59e1-4f2a-8d5e-b7b2cac97b78/gr1_lrg.jpg)
Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn - Pediatrics & Neonatology
![Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension | Circulation Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension | Circulation](https://www.ahajournals.org/cms/asset/98be50fa-64ff-47e9-b01c-9889c24e478b/2189fig01.jpeg)
Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension | Circulation
![SciELO - Brasil - Sildenafil no tratamento da hipertensão pulmonar após cirurgia cardíaca Sildenafil no tratamento da hipertensão pulmonar após cirurgia cardíaca SciELO - Brasil - Sildenafil no tratamento da hipertensão pulmonar após cirurgia cardíaca Sildenafil no tratamento da hipertensão pulmonar após cirurgia cardíaca](https://minio.scielo.br/documentstore/1678-4782/VV7bJz36dKDc6LXMgtcVTqz/c1c34fe4674e3218b256b6198a4d25ce2b6cffb1.jpg)
SciELO - Brasil - Sildenafil no tratamento da hipertensão pulmonar após cirurgia cardíaca Sildenafil no tratamento da hipertensão pulmonar após cirurgia cardíaca
![Cellular mechanisms of sildenafil actions. Reproduced with permission... | Download Scientific Diagram Cellular mechanisms of sildenafil actions. Reproduced with permission... | Download Scientific Diagram](https://www.researchgate.net/publication/44657658/figure/fig1/AS:202865118322688@1425378221612/Cellular-mechanisms-of-sildenafil-actions-Reproduced-with-permission-from-Humbert-M.png)
Cellular mechanisms of sildenafil actions. Reproduced with permission... | Download Scientific Diagram
![Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications | European Respiratory Society Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications | European Respiratory Society](https://erj.ersjournals.com/content/erj/35/2/418/F1.large.jpg?width=800&height=600&carousel=1)
Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications | European Respiratory Society
![Molecular therapy for pulmonary arterial hypertension: Sildenafil [Brand name: Revatio, Viagra and others], a cGMP-specific phosphodiestrase type 5 inhibitor used in the treatment of erectile dysfunction and pulmonary hypertension, inhibits the development Molecular therapy for pulmonary arterial hypertension: Sildenafil [Brand name: Revatio, Viagra and others], a cGMP-specific phosphodiestrase type 5 inhibitor used in the treatment of erectile dysfunction and pulmonary hypertension, inhibits the development](https://genomediscovery.org/wp-content/uploads/2018/01/Sildenafil-attenuates-Pulmonary-Arterial-Hypertension-through-down-regulation-of-Notch-3-and-Hes-5.jpg2_.jpg)
Molecular therapy for pulmonary arterial hypertension: Sildenafil [Brand name: Revatio, Viagra and others], a cGMP-specific phosphodiestrase type 5 inhibitor used in the treatment of erectile dysfunction and pulmonary hypertension, inhibits the development
![Frontiers | New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil | Oncology Frontiers | New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil | Oncology](https://www.frontiersin.org/files/Articles/627229/fonc-11-627229-HTML/image_m/fonc-11-627229-g001.jpg)
Frontiers | New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil | Oncology
![JPM | Free Full-Text | The Potential Role of Sildenafil in Cancer Management through EPR Augmentation | HTML JPM | Free Full-Text | The Potential Role of Sildenafil in Cancer Management through EPR Augmentation | HTML](https://www.mdpi.com/jpm/jpm-11-00585/article_deploy/html/images/jpm-11-00585-g001.png)
JPM | Free Full-Text | The Potential Role of Sildenafil in Cancer Management through EPR Augmentation | HTML
![Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond | Nature Reviews Drug Discovery Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd2030/MediaObjects/41573_2006_Article_BFnrd2030_Fig1_HTML.jpg)